Summary of proceedings of the 17th AGM of the Company.

Ref: NEPHROPLUS/SE/74 August 12, 2026 To To BSE Limited Na(cid:415)onal Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Lis(cid:415)ng Centre Through: NEAPS Subject: Proceedings of the 17th Annual General Meeting (“AGM”) of Nephrocare Health Services Limited (“the Company”). Dear Sir/ Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform you that the 17th Annual General Meeting ("AGM") of the Company was held today, i.e., Wednesday, August 12, 2026 at 2:30 PM IST, through Video Conferencing ("VC") / Other Audio- Visual Means ("OAVM"), wherein the businesses set out in the Notice of the AGM dated June 22, 2026, were duly transacted. In this regard, please find enclosed the proceedings of the 17th AGM of the Company, as required under Regulation 30 read with Schedule III of the SEBI Listing Regulations. Yours sincerely, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895 Encl: as above Summary of proceedings of the 17th Annual General Meeting of Nephrocare Health Services Limited The 17th Annual General Meeting (“AGM”) of Nephrocare Health Services Limited (“the Company”) was held on Wednesday, August 12, 2026, at 2.30 pm IST, through Video Conferencing/Other Audio- Visual Means (“VC/OAVM”) facility, in compliance with the General Circulars issued by the Ministry of Corporate Affairs (“MCA”) and Circulars issued by the Securities and Exchange Board of India (“SEBI”) and as per the applicable provisions of the Companies Act, 2013, and the Rules made thereunder. The deemed venue of the AGM was the Registered Office of the Company, i.e., 5th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad – 500081, Telangana, India. The following Directors were present: Sr. No. Name A(cid:425)ended through VC / OAVM from 1. Mr. Vikram Vuppala - Chairman and Managing Director and Hyderabad Chairman of the Risk Management Commi(cid:425)ee. 2. Mr. Hemant Sultania - Independent Director and Chairman Gurugram of the Audit Commi(cid:425)ee 3. Mr. Om Prakash Manchanda - Independent Director & Gurugram Chairman of Nomina(cid:415)on and Remunera(cid:415)on Commi(cid:425)ee 4. Mr. Gaurav Sharma - Nominee Director & Chairman of the Mumbai Stakeholders Rela(cid:415)onship Commi(cid:425)ee 5. Mr. Vishal Vijay Gupta - Nominee Director Bangalore 6. Mr. Sunil Kumar Thakur - Nominee Director Delhi 7. Ms. Anne(cid:425)e Kumlien - Independent Director France 8. Dr. Ajay Bakshi - Independent Director New Delhi In attendance: Sr. No. Name A(cid:425)ended through VC/OAVM from 1. Mr. Kamal D Shah - Co-founder Hyderabad 2. Mr. Rohit Singh - Group CEO Hyderabad 3. Mr. Prashant Goenka – Group CFO Hyderabad 4. Mr. Kishore Kathri - Company Secretary & Head Legal Hyderabad 5. Mr. Amit Kumar Bajaj - Partner, BSR and Co, Chartered Hyderabad Accountants, Statutory Auditors 6. Mr. Vaibhav Dandawate, Partner - Makarand M. Joshi & Co., Mumbai Secretarial Auditor 7. Ms. Rashida Ha(cid:415)m Adenwala, Founder Partner R & A Hyderabad Associates, Company Secretaries - Scru(cid:415)nizer Quorum of the Meeting A total of 74 Members attended the Meeting. Chairman Mr. Vikram Vuppala, Chairman & Managing Director, chaired the meeting. Proceedings Mr. Kishore Kathri, Company Secretary, welcomed the members of the Company and briefed them about the process to participate in the meeting. He informed that the statutory registers and other documents as required under applicable laws were made available for inspection on the website of the Company. It was further informed that as the AGM was being held through VC/OAVM, the facility for appointment of proxies by the members was not applicable and hence, the proxy register was not available for inspection. The members were also briefed about the process for questions & answers and e-voting. Mr. Vikram Vuppala, Chairman & Managing Director, chaired the meeting and welcomed the members to the 17th AGM of the Company and requested the Directors who had joined the 17th AGM through VC to introduce themselves. Accordingly, the Directors introduced themselves and confirmed their presence at the AGM. The Chairman also acknowledged the attendance of representatives of M/s. B S R and Co., Chartered Accountants, the Statutory Auditors of the Company, the representative of Makarand M. Joshi & Co., the Secretarial Auditor and Ms. Rashida Hatim Adenwala, Practising Company Secretary as the Scrutinizer for the meeting. The requisite quorum being present as per statutory requirements, he called the meeting to order. Thereafter, the Chairman delivered his speech. With the permission of the Members present, the Notice convening the 17th AGM and the Statutory Auditor’s Report were taken as read. The Chairman informed the Members that the Statutory Auditor’s Report did not contain any qualifications, reservations, adverse remarks or disclaimers. Thereafter, the Chairman proceeded to take up the resolutions set out in the Notice of the AGM. In respect of Item Nos. 5 and 6, in which Mr. Vikram Vuppala, Chairman & Managing Director, was interested, Mr. Om Prakash Manchanda, Independent Director, chaired the proceedings and conducted the business relating to the said items. Upon conclusion of Item Nos. 5 and 6, Mr. Vikram Vuppala resumed the Chair and proceeded with the remaining business of the Meeting. The following items were transacted at the AGM: S. No. Par(cid:415)culars of Resolu(cid:415)on Type of Resolu(cid:415)on 1. Adop(cid:415)on of the Audited Standalone and Consolidated Financial Ordinary Statements for the financial year ended March 31, 2026 together with the Auditors’ Report and Board’s Report thereon. 2. Re-appointment of Mr. Gaurav Sharma (DIN: 03311656) Nominee Ordinary Director (Non-Execu(cid:415)ve category), as a Director liable to re(cid:415)re by rota(cid:415)on. 3. Approval for the NephroPlus Employee Stock Op(cid:415)on Scheme, 2026 Special 4. Approve grant of Employee Stock Op(cid:415)ons to the employees of Special subsidiary, associate company incorporated in India or outside India, or holding company of the Company under NephroPlus Employee Stock Op(cid:415)on Scheme – 2026. 5. Approval for clarificatory amendment to the special resolu(cid:415)on Special passed by the shareholders with respect to the remunera(cid:415)on of Mr. Vikram Vuppala (DIN: 02847323), Chairman & Managing Director of the Company. 6. Approval for the Promote Incen(cid:415)ve Arrangement pursuant to the Ordinary Promote Agreement dated July 25, 2025, entered by Mr. Vikram Vuppala, Founder, Promoter, Chairman and Managing Director, with certain Shareholders of the Company. Thereafter, the Chairman requested the Members who had not already cast their votes through remote e-voting to exercise their voting rights during the AGM through the e-voting facility made available for the Meeting. The Chairman then invited the registered speaker shareholders to express their views and raise queries, if any. The queries and observations raised by the speaker shareholders were duly responded to and appropriately addressed by the Management. It was further informed that Ms. Rashida Hatim Adenwala, Founder Partner R & A Associates, Company Secretaries (M. No. 4020), had been appointed as the Scrutinizer to scrutinize the votes cast through e-voting at the AGM & remote e-voting and submit a consolidated report thereon. The Chairman authorized Mr. Kishore Kathri, Company Secretary and Compliance officer, to receive the Scrutinizer’s Consolidated Report on all the resolutions as set out in the Notice of AGM, and related documents, declare th [Showing first 8,000 characters — download PDF for full document]